arrow
K

Karolin Trautmann‐Grill

Technische Universität Dresden
H指数:18
被引数:1,201
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quality of life with nivolumab and AVD first-line treatment of Hodgkin lymphoma in the Phase II GHSG NIVAHL trial

纳武利尤单抗联合AVD方案一线治疗霍奇金淋巴瘤的II期GHSG NIVAHL试验中的生活质量

2026-09-300
OAAI
Steady-state mobilization with on-demand plerixafor after CD38 antibody-based induction in multiple myeloma patients

CD38抗体诱导后按需使用plerixafor的多发性骨髓瘤患者稳态动员

2026-03-010
OAAI
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase

慢性髓性白血病急变期预后评分系统的开发

Leukemia
IF13.4
2026-02-190
OA
Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia for the British Journal of Haematology
2026-01-010
PRE
High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia to the British Journal of Haematology

高预处理外周血T细胞受体克隆性可预测免疫性血小板减少症对英国血液学杂志的反应延长

2026-01-010
OAAI
Prospective systematic classification of causes of death in the course of multiple myeloma

多发性骨髓瘤病程中死亡原因的前瞻性系统分类

2025-10-200
OA
Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial

低甲基化治疗联合或不联合艾曲波帕治疗老年急性髓系白血病患者:来自随机、安慰剂对照的II期DELTA试验结果

2025-10-020
OAAI
Antithrombotic treatment for cardiological interventions in patients with thrombocytopenia in oncological diseases: Consensus paper of the Working Group on Cardiovascular Hemostasis and Antithrombotic Treatment (AG19) of the German Cardiac Society (DGK), the German Society for Transfusion Medicine and Immunohematology (DGTI), the German Society for Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Haemostasis Research (GTH)

对于肿瘤疾病患者心内科介入治疗中的抗血栓治疗:德国心脏学会(DGK)心血管止血与抗血栓治疗工作组(AG19)、德国输血医学与免疫血液学学会(DGTI)、德国血液学与肿瘤医学学会(DGHO)以及血栓与止血研究学会(GTH)的共识文件

2025-09-010
PRE
Sustained Survival Benefit of Emicizumab and Postponed Immunosuppression in Acquired Hemophilia A

艾美珠单抗的持续生存获益及获得性血友病A中免疫抑制治疗的推迟

2025-08-140
OAAI
Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?

在新疗法时代,复发/难治性多发性骨髓瘤的自体挽救性移植仍有一席之地吗?

2025-02-260
OAAI
Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiary

在德国,emicizumab对无因子VIII抑制剂的严重a型血友病患者的疗效: smart mediceary记录的现实数据评估

2024-11-290
OAAI
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study
2023-11-0118
PRE